- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01628835
Low Glycemic Index (GI) Diet Management for Pregnant Woman With Overweight
Low Glycemic Index Diet Intervention on Insulin Resistance of Overweight Pregnant Women.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Overweight in pregnant women increases maternal insulin resistance and risk of adverse pregnancy outcomes. Recent evidence from both animal studies and human subject studies shows that adverse environmental exposures during pregnancy result in adverse influence on offsprings. The hypothesis of the current study is that the healthy intervention during pregnancy to overweight pregnant women--low glycemic diet, may improve the maternal and neonatal insulin resistance at birth.
The current study adopts randomized, single-blinded, controlled intervention trial, gives low glycemic index diet intervention based on the national diet and physical activity recommendations for pregnant women to the intervention group and only national diet recommendations to the control group. Four diet consultation interviews will be done,at baseline (first prenatal examination), the end of the 1st trimester, the 2nd trimester and the 3rd trimester respectively, including diet assessment and diet consultation specifically to adopting low glycemic diet. Glycemic load of diet will be calculated based on 24 hour diet recall data for each individual at every visit to help to lower their diet glycemic load by modifying some daily foods. The effect of intervention is investigated by comparing the insulin resistance levels between the two arms at birth and when infants are at age 2. For discrete traits, such as incidence of gestational diabetes and gestational hypertension, Person's chi-square tests were used. For continuous traits, such as insulin resistance index, maternal weight gain and neonatal birth weight, we use t-tests for comparisons between two groups. The study expects that long-term low GI diet intervention have beneficial effects on controlling maternal and neonatal insulin resistance to overweight women and long term health.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shanghai, China, 201102
- International Peace Maternity and Child Care Centers of Communications University
-
-
Jiangsu
-
Kunshan city, Jiangsu, China
- Kunshan Maternal and Child Health Care Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion
- Singleton pregnancy;
- Pregnant women with BMI≥24 kg/m2 at first antenatal examination;
- aged 18 years to 45 years;
- The week of first prenatal examination equal to or less than 12 weeks;
- Take routine prenatal examination;
- Willing and able to give informed consent. Exclusion
- Artificial impregnation;
- History of hypertension, diabetes, coronary heart disease or mental disorder;
- With Special diet habit(e.g. vegetarianism/ veganism).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low dietary glycemic index diet
Based on the national diet and physical activity recommendations for pregnant women (total energy intake, protein and vitamin etc.), counseling for a low dietary glycemic index diet will be provided.
|
Based on the national diet and physical activity recommendations for pregnant women (total energy intake, protein and vitamin etc.), counseling for a low dietary glycemic index diet will be provided
|
|
Active Comparator: National recommendation diet
Provision of food and dietary counseling according to the national prenatal nutrition recommendation without GI information
|
Provision of food and dietary counseling according to the national prenatal nutrition recommendation without GI information
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal insulin resistance
Time Frame: During pregnancy
|
During pregnancy
|
|
|
Cord blood C-peptide
Time Frame: at delivery
|
at delivery
|
|
|
Maternal weight gain
Time Frame: measured before delivery
|
measured before delivery (minus pre-conceptual body weight)
|
measured before delivery
|
|
Incidence of gestational diabetes
Time Frame: during pregnancy
|
from 1st antenatal visit to delivery
|
during pregnancy
|
|
Incidence of macrosomia
Time Frame: at delivery
|
birth weight >= 4000g
|
at delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of gestational hypertension
Time Frame: during pregnancy
|
proportion of patients with SBP/SBP>=140/90 for 3 visits
|
during pregnancy
|
|
Mean infant birth weight
Time Frame: at delivery
|
at delivery
|
|
|
cesarean
Time Frame: at delivery
|
at delivery
|
|
|
head circumference
Time Frame: at delivery
|
at delivery
|
|
|
Mean gestational age
Time Frame: at delivery
|
at delivery
|
|
|
Incidence of premature delivery
Time Frame: at delivery
|
gestational age <37 week at delivery
|
at delivery
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- version1.0
- NSFC 81273168 (Other Grant/Funding Number: National Science Fundation of China)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
-
National Taiwan University HospitalCompleted
Clinical Trials on Low dietary glycemic index diet
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Completed
-
Universidad Autonoma de Baja CaliforniaTerminated
-
University of SaskatchewanRoyal University Hospital FoundationCompletedGlucose IntoleranceCanada
-
Sibylle Kranz, PhD, RDNRecruitingDiet ModificationUnited States
-
Brigham and Women's HospitalEpilepsy FoundationNot yet recruiting
-
Chinese University of Hong KongUnknown
-
University of SaskatchewanHeart and Stroke Foundation of CanadaCompletedHypercholesterolemiaCanada
-
Queen's UniversityTerminatedObesity | Cardiovascular Disease | Metabolic SyndromeCanada
-
Columbia UniversityAmerican Cancer Society, Inc.; Gabrielle's Angel FoundationActive, not recruitingAcute Lymphoblastic Leukemia, Pediatric | Obesity, PediatricUnited States
-
Taipei Medical University WanFang HospitalUnknown